申请人:NANTBIO, INC.
公开号:US10344026B2
公开(公告)日:2019-07-09
Compounds and compositions are presented that inhibit K-Ras, and especially mutant K-Ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.
本文介绍了抑制 K-Ras,特别是突变型 K-Ras 的化合物和组合物。某些化合物优先或甚至选择性地抑制特定形式的突变 K-Ras,特别是 G12D 突变形式。